SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17079006
Source:
http://linkedlifedata.com/resource/pubmed/id/17079006
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0246415
,
umls-concept:C0282460
,
umls-concept:C0332174
,
umls-concept:C1140680
,
umls-concept:C1514756
pubmed:issue
3
pubmed:dateCreated
2007-2-19
pubmed:abstractText
To determine the response rate of weekly docetaxel in women with relapsed epithelial ovarian cancer previously treated with paclitaxel and at least one line of platinum-based chemotherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0090-8258
pubmed:author
pubmed-author:BealePP
,
pubmed-author:BuckMM
,
pubmed-author:FitzharrisBB
,
pubmed-author:GebskiVV
,
pubmed-author:GoldrickAA
,
pubmed-author:RischinDD
,
pubmed-author:Stuart-HarrisRR
,
pubmed-author:TinkerA VAV
pubmed:issnType
Print
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
647-53
pubmed:meshHeading
pubmed-meshheading:17079006-Antineoplastic Agents
,
pubmed-meshheading:17079006-Cohort Studies
,
pubmed-meshheading:17079006-Drug Administration Schedule
,
pubmed-meshheading:17079006-Drug Resistance, Neoplasm
,
pubmed-meshheading:17079006-Female
,
pubmed-meshheading:17079006-Humans
,
pubmed-meshheading:17079006-Middle Aged
,
pubmed-meshheading:17079006-Ovarian Neoplasms
,
pubmed-meshheading:17079006-Paclitaxel
,
pubmed-meshheading:17079006-Taxoids
pubmed:year
2007
pubmed:articleTitle
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01.
pubmed:affiliation
Division of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II